Anti-inflammatory aminoacetylenic isoindoline-1,3-dione derivatives modulate cytokines production from different spleen cell populations.

[1]  Mohammad A. Ghattas,et al.  Non-selective inhibition of cyclooxygenase enzymes by aminoacetylenic isoindoline 1,3-diones. , 2012, Inflammation & allergy drug targets.

[2]  P. Conaghan.  A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity , 2011, Rheumatology International.

[3]  U. Lopes,et al.  Thalidomide modulates Mycobacterium leprae-induced NF-κB pathway and lower cytokine response. , 2011, European journal of pharmacology.

[4]  J. Kanno,et al.  Mast cell development and biostresses: different stromal responses in bone marrow and spleen after treatment of myeloablater, 5-fluorouracil, and inflammatory stressor, lipopolysaccharide. , 2011, Biological & pharmaceutical bulletin.

[5]  Michelle R. Lennartz,et al.  Protein Kinase C and Toll-Like Receptor Signaling , 2011, Enzyme research.

[6]  S. Ishihara,et al.  Decreased production of interleukin‐10 and transforming growth factor‐β in Toll‐like receptor‐activated intestinal B cells in SAMP1/Yit mice , 2010, Immunology.

[7]  Y. Hasegawa,et al.  Thalidomide attenuates airway hyperresponsiveness and eosinophilic inflammation in a murine model of allergic asthma. , 2010, Biological & pharmaceutical bulletin.

[8]  Shuang Huang,et al.  An Atypical Protein Kinase C (PKCζ) Plays a Critical Role in Lipopolysaccharide-Activated NF-κB in Human Peripheral Blood Monocytes and Macrophages1 , 2009, The Journal of Immunology.

[9]  F. Hassan,et al.  Thalidomide inhibits lipopolysaccharide-induced tumor necrosis factor-α production via down-regulation of MyD88 expression , 2009, Innate immunity.

[10]  R. Hays,et al.  Evidence-based effect size estimation:An illustration using the case of acupuncture for cancer-related fatigue , 2009, BMC complementary and alternative medicine.

[11]  W. Schiemann,et al.  Transcriptional and Translational Regulation of TGF-β Production in Response to Apoptotic Cells1 , 2008, The Journal of Immunology.

[12]  Arthur,et al.  The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling , 2008, Nature Immunology.

[13]  G. Adema,et al.  Toll‐like receptor signalling on Tregs: to suppress or not to suppress? , 2008, Immunology.

[14]  Z. Berneman,et al.  Regulatory T Cells and Human Disease , 2008, Clinical & developmental immunology.

[15]  S. John,et al.  CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages , 2007, Proceedings of the National Academy of Sciences.

[16]  K. Matalka,et al.  The differential effect of Eriobotrya japonica hydrophilic leaf extract on cytokines production and modulation , 2007 .

[17]  L. Baiza-Durán,et al.  Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation , 2007, British Journal of Ophthalmology.

[18]  D. Kabelitz.  Expression and function of Toll-like receptors in T lymphocytes. , 2007, Current opinion in immunology.

[19]  M. Netea,et al.  Toll-like receptors on regulatory T cells: expanding immune regulation. , 2006, Trends in immunology.

[20]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[21]  K. Matalka,et al.  Measurement of protein cytokines in tissue extracts by enzyme-linked immunosorbent assays: application to lipopolysaccharide-induced differential milieu of cytokines. , 2005, Neuro endocrinology letters.

[22]  Y. Hashimoto,et al.  Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide. , 2005, Bioorganic & medicinal chemistry.

[23]  Qiao-Hong Chen,et al.  Design, synthesis, and biological evaluation of N-acetyl-2-carboxybenzenesulfonamides: a novel class of cyclooxygenase-2 (COX-2) inhibitors. , 2005, Bioorganic & medicinal chemistry.

[24]  E. Tremoli,et al.  Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-alpha and phorbol ester in human endothelial cells. , 2005, Cardiovascular research.

[25]  E. De Clercq,et al.  Are 5'-O-carbamate-2',3'-dideoxythiacytidine new anti-HIV and anti-HBV nucleoside drugs or prodrugs? , 2003, Bioorganic & medicinal chemistry letters.

[26]  I. Caramalho,et al.  Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide , 2003, The Journal of experimental medicine.

[27]  B. Palmer,et al.  Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity. , 1998, British Journal of Cancer.

[28]  H. Ghantous,et al.  SYNTHESIS AND BIOLOGICAL EVALUATION OF N-(4-T-AMINO-2-BUTYNYLOXY) AND N-(4-T-AMINO-2-BUTYNYL) PHTHALIMIDES , 1980 .

[29]  Song Jiang,et al.  Toll-like receptor signaling in cell proliferation and survival. , 2010, Cytokine.